Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19901363 | 1.00 | ECE1 (0.41) | ECE1CA2CA1GRIA1CA14 | |
| SCHEMBL19901361 | 1.00 | ECE1 (0.41) | ECE1CA2CA1GRIA1CA14 | |
| SCHEMBL18198006 | 0.91 | ECE1 (0.37) | ECE1CA2CA1GRIA1CA14 | |
| SCHEMBL18198002 | 0.91 | ECE1 (0.37) | ECE1CA2CA1GRIA1CA14 | |
| SCHEMBL18198015 | 0.91 | ECE1 (0.37) | ECE1CA2CA1GRIA1CA14 | |
| SCHEMBL18198033 | 0.87 | ALDH1A1 (0.37) | ECE1GRIA1CA14 | |
| SCHEMBL18198034 | 0.87 | ALDH1A1 (0.37) | ECE1GRIA1CA14 | |
| SCHEMBL18198029 | 0.87 | ALDH1A1 (0.37) | ECE1GRIA1CA14 | |
| SCHEMBL18198030 | 0.81 | CNR2 (0.41) | CA2CA1CNR2 | |
| SCHEMBL18198038 | 0.81 | CNR2 (0.41) | CA2CA1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9902726-B2 | Pyridone-sulfone morphinan analogs as opioid receptor ligands | PURDUE PHARMA L.P. (US) | 2018-02-27 | — | — | US | disclosed |
| US-9902726-B2 | Pyridone-sulfone morphinan analogs as opioid receptor ligands | PURDUE PHARMA L.P. (US) | 2018-02-27 | — | — | US | disclosed |